Results 71 to 80 of about 4,306 (252)

Melasma Management: A Comprehensive Review of Treatment Strategies Including BTX‐A

Journal of Cosmetic Dermatology, Volume 24, Issue 2, February 2025.
ABSTRACT Background Botulinum toxin A (BTX‐A) is a widely utilized protein derived from the bacterium Clostridium botulinum, known for its effectiveness in treating various medical conditions involving muscle spasticity, involuntary muscle movements, and pain disorders.
Barbara Kania, Margarita Lolis, David Goldberg   +2 more
wiley   +1 more source

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Clinical Ophthalmology, 2021
Laura R Steeples,1,2 Sasa Pockar,1 Nicholas P Jones,1,2 Inês Leal3,4 1Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; 2Faculty of Biology, Medicine &
Steeples LR, Pockar S, Jones NP, Leal I
doaj  

A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) [PDF]

, 2017
PURPOSE: The aim of this study was to assess the effectiveness and safety of ILUVIEN® in patients with chronic diabetic macular edema (DME) who were insufficiently responsive to prior therapies.
Alves, D, Amaro, M, Cunha-Vaz, J, Figueira, J, Henriques, J, Rosas, V   +5 more
core   +2 more sources

Fluocinolone acetonide topical oil for scalp psoriasis

Journal of Dermatological Treatment, 2004
Numerous preparations that are available for the treatment of psoriasis of the scalp contain high potency steroids, such as betamethasone dipropionate lotion or clobetasol propionate solution. Of special interest is a currently marketed oil preparation that contains the steroid fluocinolone acetonide (0.01%), classified as low potency (Class 6) steroid.
H Mendelsohn, M Pugliese, Howard I. Maibach, N. J. Lowe, M Pauporte, DJ Friedman, I Cargill, R.G. Ramirez   +7 more
openaire   +3 more sources

Clinical Trials Conducted on Herbal Remedies for the Treatment of Melasma: A Scoping Review

Journal of Cosmetic Dermatology, Volume 24, Issue 2, February 2025.
ABSTRACT Introduction Melasma, also known as chloasma, is a common skin disorder characterized by acquired hyperpigmentation. Many patients with this condition prefer using herbal remedies instead of chemical agents. This study aims to review clinical trials conducted on the effectiveness of herbal remedies in treating melasma.
Mohammad Mahdi Parvizi, Maryam Hekmat, Nahid Yousefi, Rojan Javaheri, Arman Mehrzadeh, Nasrin Saki   +5 more
wiley   +1 more source

Use of Intravitreal Triamcinolone in the Treatment of Macular Edema Related to Retinal Vein Occlusion [PDF]

, 2008
ObjectiveTo analyze the increasing trend of intravitreal triamcinolone (IVTA) use in the treatment of retinal vein occlusion-related macular edema.MethodsWe performed MEDLINE/PUBMED searches (September 1984 - December 2007) to identify articles ...
D. Kuppermann, Baruch, Kenney, M. Cristina, Sharma, Ashish   +2 more
core   +2 more sources

The Efficacy of Topical Cosmetic Containing Alpha‐Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split‐Face, Evaluator‐Blinded Randomized Pilot Study

Journal of Cosmetic Dermatology, Volume 24, Issue 1, January 2025.
ABSTRACT Background While the gold standard treatment for melasma is triple combination cream (TCC), arbutin and kojic acid demonstrate their benefits and may be used as an alternative. Aims To investigate the efficacy of cream containing alpha‐arbutin 5% and kojic acid 2% (AAK) compared with TCC for melasma treatment.
Pimpa Tantanasrigul, Apinya Sripha, Bunchai Chongmelaxme   +2 more
wiley   +1 more source

Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema

Drug Design, Development and Therapy, 2013
Wyatt B Messenger, Robert M Beardsle, Christina J FlaxelCasey Eye Institute, Oregon Health and Science University, Portland, OR, USAAbstract: Diabetic macular edema (DME) remains one of the leading causes of moderate to severe vision loss. Although laser
Messenger WB, Beardsley RM, Flaxel CJ
doaj  

Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema [PDF]

, 2014
Diabetic macular oedema (DMO) is a leading cause of vision loss in the working-age population worldwide. Corticosteroid drugs have been demonstrated to inhibit the expression of both the vascular endothelial growth factor (VEGF) gene and other anti ...
Alkabes, M, Dutra-Medeiros, M, Nucci, P
core   +1 more source

Review of Applications of Microneedling in Melasma

Journal of Cosmetic Dermatology, Volume 24, Issue 1, January 2025.
ABSTRACT Background Melasma, a common skin pigmentation disease, can negatively impact patients' mental health, social interactions, and physical appearance. Although we now have several treatments accessible, such as medicines, chemical peels, and phototherapy, which can help ease symptoms to some extent, the requirement for a long‐term effective and ...
Wenwen Chen, Xingling Jian, Bo Yu
wiley   +1 more source